Table 3 from A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
收藏数据链接：
官方服务：
资源简介：
Efficacy in the dose-expansion phase (intent-to-treat population; N = 170).
创建时间：
2024-10-15
